Curis Inc
CRIS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001108205
No open-market purchases or sales by Curis Inc insiders were filed in the last 90 days; 37 institutions reported holding it in 13F filings for Q2 2026, worth $7.96M in total; Maverick Capital is the only superinvestor holding it.
Q2 2024 vs. Q1 2024
How the institutions holding Curis Inc changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 36 | 34 | −2 |
| Shares | 2.09M | 2.30M | +216.4K (+10.4%) |
| Value | $22.7M | $15.9M | −$6.80M (−29.9%) |
New holders (2)
Institutions that held Curis Inc at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| LMR Partners LLP | 10,102 | $69.7K | 0.00% |
| FMR LLC | 5 | $35 | 0.00% |
Sold out (4)
Institutions that held Curis Inc at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Arnhold LLC | 16,348 | $177.7K |
| LPL Financial LLC | 10,522 | $114.4K |
| Wells Fargo & Company | 47 | $511 |
| GWM Advisors LLC | 3 | $33 |